Financial Tearsheet






Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

23 Aug 21
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
By achieving commercial scale production of CBG, the companies are on track to enable access to rare cannabis molecules TORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks
09 Aug 21
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Canaccord Genuity 41st Annual Growth Conference on
06 Aug 21
Cronos Group Appoints Bob Madore as Chief Financial Officer
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Bob Madore as Chief Financial Officer, effective August 9, 2021, who will succeed Jerry Barbato.

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Events

10 August 2021 at 1:30 PM EDT
Canaccord Genuity 41st Annual Growth Conference
06 August 2021 at 8:30 AM EDT
Cronos Group Second Quarter 2021 Earnings Conference Call
25 June 2021 at 11:00 AM EDT
2021 Annual and Special Meeting of Shareholders